Literature DB >> 27931028

Sustained Effects of Neonatal Systemic Lipopolysaccharide on IL-1β and Nrf2 in Adult Rat Substantia Nigra Are Partly Normalized by a Spirulina-Enriched Diet.

Jaspal Patil1, Ashok Matte, Hans Nissbrandt, Carina Mallard, Mats Sandberg.   

Abstract

BACKGROUND/AIM: Neonatal infection can sensitize the adult substantia nigra (SN) to secondary insults, causing a decrease in antioxidant capacity which may lead to Parkinson's disease in adults. We studied the prolonged effect of systemic infection by (i.p.) administration of lipopolysaccharide (LPS) on interleukin (IL)-1β, the antioxidant regulator nuclear factor-erythroid 2-related factor 2 (Nrf2), and the peroxisome proliferator-activated receptor γ coactivator (PGC)-1α in rat SN. METHOD AND
RESULTS: Five-day-old rat pups were treated with LPS (i.p. 2 mg/kg). After 65 days, the mRNA level of IL-1β was significantly increased, in parallel with a decrease in that of the rate-limiting enzyme in glutathione synthesis, the γ-glutamylcysteine ligase catalytic subunit (γGCLc), Nrf2, and brain-derived neurotrophic factor (BDNF). Protein levels of γGCLc and Nrf2 were decreased while IL-1β protein was significantly increased. These LPS-induced long-term changes correlated with a decrease in phosphorylated (active) AKT (pAKT) and phosphorylated (inactive) GSK-3β (pGSK-3β). In another set of experiments, a 0.1% Spirulina-containing diet was given to lactating mothers 24 h before the LPS treatment of the pups. The Spirulina-supplemented diet decreased IL-1β protein expression in SN and elevated the mRNA level of γGCLc, Nrf2 protein, PGC-1α protein, and pAKT.
CONCLUSION: Early-life infection can negatively affect Nrf2, pAKT, and pGSK-3β for a long time in SN. A diet enriched with antioxidant and anti-inflammatory phytochemicals can partly restore some, but not all, of the effects on the antioxidant defense, possibly via normalizing effects on pAKT.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27931028      PMCID: PMC5266664          DOI: 10.1159/000452714

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  41 in total

1.  SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β.

Authors:  Seo-Hyun Cho; Jason A Chen; Faten Sayed; Michael E Ward; Fuying Gao; Thi A Nguyen; Grietje Krabbe; Peter Dongmin Sohn; Iris Lo; Sakura Minami; Nino Devidze; Yungui Zhou; Giovanni Coppola; Li Gan
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

2.  Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system.

Authors:  Ingrid Strömberg; Carmelina Gemma; Jennifer Vila; Paula C Bickford
Journal:  Exp Neurol       Date:  2005-09-19       Impact factor: 5.330

3.  α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.

Authors:  Isabel Lastres-Becker; Ayse Ulusoy; Nadia G Innamorato; Gurdal Sahin; Alberto Rábano; Deniz Kirik; Antonio Cuadrado
Journal:  Hum Mol Genet       Date:  2012-04-18       Impact factor: 6.150

4.  Early-life infection leads to altered BDNF and IL-1beta mRNA expression in rat hippocampus following learning in adulthood.

Authors:  Staci D Bilbo; Ruth M Barrientos; Andrea S Eads; Alexis Northcutt; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Brain Behav Immun       Date:  2007-11-07       Impact factor: 7.217

5.  Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.

Authors:  Ana I Rojo; Nadia G Innamorato; Ana M Martín-Moreno; María L De Ceballos; Masayuki Yamamoto; Antonio Cuadrado
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

6.  Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.

Authors:  Malin von Otter; Sara Landgren; Staffan Nilsson; Dragana Celojevic; Petra Bergström; Anna Håkansson; Hans Nissbrandt; Marek Drozdzik; Monika Bialecka; Mateusz Kurzawski; Kaj Blennow; Michael Nilsson; Ola Hammarsten; Henrik Zetterberg
Journal:  BMC Med Genet       Date:  2010-03-02       Impact factor: 2.103

Review 7.  Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.

Authors:  Ana L Cardoso; Joana R Guedes; Maria C Pedroso de Lima
Journal:  Curr Opin Pharmacol       Date:  2015-09-25       Impact factor: 5.547

8.  Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

Authors:  Malin von Otter; Sara Landgren; Staffan Nilsson; Madeleine Zetterberg; Dragana Celojevic; Petra Bergström; Lennart Minthon; Nenad Bogdanovic; Niels Andreasen; Deborah R Gustafson; Ingmar Skoog; Anders Wallin; Gunnar Tasa; Kaj Blennow; Michael Nilsson; Ola Hammarsten; Henrik Zetterberg
Journal:  Mech Ageing Dev       Date:  2010-01-12       Impact factor: 5.432

9.  Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity.

Authors:  Yi-Hsien Tsou; Ching-Ting Shih; Cheng-Hsin Ching; Jui-Yen Huang; Chauying J Jen; Lung Yu; Yu-Min Kuo; Fong-Sen Wu; Jih-Ing Chuang
Journal:  Exp Neurol       Date:  2014-10-05       Impact factor: 5.330

10.  The protease Omi regulates mitochondrial biogenesis through the GSK3β/PGC-1α pathway.

Authors:  R Xu; Q Hu; Q Ma; C Liu; G Wang
Journal:  Cell Death Dis       Date:  2014-08-14       Impact factor: 8.469

View more
  2 in total

1.  Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders.

Authors:  Amin Mottahedin; Maryam Ardalan; Tetyana Chumak; Ilse Riebe; Joakim Ek; Carina Mallard
Journal:  Front Cell Neurosci       Date:  2017-07-11       Impact factor: 5.505

Review 2.  Spirulina Microalgae and Brain Health: A Scoping Review of Experimental and Clinical Evidence.

Authors:  Vincenzo Sorrenti; Davide Augusto Castagna; Stefano Fortinguerra; Alessandro Buriani; Giovanni Scapagnini; Donald Craig Willcox
Journal:  Mar Drugs       Date:  2021-05-22       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.